Adaptin: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | |||
*AP-α-2 | |||
[[1b9x]], [[1qts]] – mAP appendage domain – mouse<br /> | **[[1b9x]], [[1qts]] – mAP appendage domain – mouse<br /> | ||
[[1qtp]] – mAP appendage domain (mutant)<br /> | **[[1qtp]] – mAP appendage domain (mutant)<br /> | ||
[[1ky6]], [[1kyd]] – mAP appendage domain + epsin peptide<br /> | **[[1ky6]], [[1kyd]] – mAP appendage domain + epsin peptide<br /> | ||
[[1ky7]] – mAP appendage domain + amphiphysin peptide<br /> | **[[1ky7]] – mAP appendage domain + amphiphysin peptide<br /> | ||
[[1kyf]], [[1kyu]] – mAP appendage domain + eps15 peptide<br /> | **[[1kyf]], [[1kyu]] – mAP appendage domain + eps15 peptide<br /> | ||
[[1w80]], [[2vj0]] – mAP appendage domain + synaptojanin peptide<br /> | **[[1w80]], [[2vj0]] – mAP appendage domain + synaptojanin peptide<br /> | ||
[[3hs8]] – mAP appendage domain + intersectin peptide<br /> | **[[3hs8]] – mAP appendage domain + intersectin peptide<br /> | ||
*AP-β | |||
[[1e42]] – hAP-1 appendage domain - human<br /> | **[[1e42]] – hAP-1 appendage domain - human<br /> | ||
[[2g30]] – hAP-1 appendage domain + ARH peptide<br /> | **[[2g30]] – hAP-1 appendage domain + ARH peptide<br /> | ||
[[3h1z]] – hAP-1 appendage domain + PTDINSPKI-γ peptide<br /> | **[[3h1z]] – hAP-1 appendage domain + PTDINSPKI-γ peptide<br /> | ||
[[3hs9]] – hAP-1 appendage domain + intersectin peptide<br /> | **[[3hs9]] – hAP-1 appendage domain + intersectin peptide<br /> | ||
[[2iv9]] – hAP-2 appendage domain + eps15 peptide<br /> | **[[2iv9]] – hAP-2 appendage domain + eps15 peptide<br /> | ||
[[2iv8]] – hAP-2 appendage domain + B-arrestin peptide<br /> | **[[2iv8]] – hAP-2 appendage domain + B-arrestin peptide<br /> | ||
*AP-γ | |||
[[1iu1]] – hAP-1 ear domain<br /> | **[[1iu1]] – hAP-1 ear domain<br /> | ||
[[1gyu]], [[2a7b]] – mAP-1 appendage domain <br /> | **[[1gyu]], [[2a7b]] – mAP-1 appendage domain <br /> | ||
[[1gyv]], [[1gyw]], [[3zy7]] – mAP-1 appendage domain (mutant)<br /> | **[[1gyv]], [[1gyw]], [[3zy7]] – mAP-1 appendage domain (mutant)<br /> | ||
[[2e9g]], [[4bcx]] – hAP-2 ear domain<br /> | **[[2e9g]], [[4bcx]] – hAP-2 ear domain<br /> | ||
[[2ymt]] – hAP-2 ear domain + peptide<br /> | **[[2ymt]] – hAP-2 ear domain + peptide<br /> | ||
[[3zhf]] – hAP-2 ear domain + large envelope protein peptide<br /> | **[[3zhf]] – hAP-2 ear domain + large envelope protein peptide<br /> | ||
*AP-δ-1 | |||
[[4afi]] – hAP-1/vesicle-associated membrane protein 7<br /> | **[[4afi]] – hAP-1/vesicle-associated membrane protein 7<br /> | ||
*AP-μ | |||
[[3h85]] – rAP-1 appendage domain + PTDINSPKIγ peptide<br /> | **[[3h85]] – rAP-1 appendage domain + PTDINSPKIγ peptide<br /> | ||
[[4emz]], [[4en2]] – mAP-1 sorting motif recognition domain + nef + MHC-I<br /> | **[[4emz]], [[4en2]] – mAP-1 sorting motif recognition domain + nef + MHC-I<br /> | ||
[[1bw8]], [[1i31]] – rAP-2 + EGFR peptide<br /> | **[[1bw8]], [[1i31]] – rAP-2 + EGFR peptide<br /> | ||
[[1bxx]] – rAP-2 + TGN38 peptide<br /> | **[[1bxx]] – rAP-2 + TGN38 peptide<br /> | ||
[[1hes]] – rAP-2 + selectin peptide<br /> | **[[1hes]] – rAP-2 + selectin peptide<br /> | ||
[[2bp5]] – rAP-2 + purinoceptor peptide<br /> | **[[2bp5]] – rAP-2 + purinoceptor peptide<br /> | ||
[[2pr9]] – rAP-2 + GABA receptor peptide<br /> | **[[2pr9]] – rAP-2 + GABA receptor peptide<br /> | ||
*AP-α + AP-β + AP-μ + AP-σ | |||
[[2vgl]] – rAPα-2 + APβ-1 + APμ-1 + APσ-1 <br /> | **[[2vgl]] – rAPα-2 + APβ-1 + APμ-1 + APσ-1 <br /> | ||
[[2jkr]], [[2jkt]] – mAPα-2 + APβ-1 + APμ-1 + APσ-1 + CD4 peptide<br /> | **[[2jkr]], [[2jkt]] – mAPα-2 + APβ-1 + APμ-1 + APσ-1 + CD4 peptide<br /> | ||
[[2xa7]] – rAPα-2 + APβ + APμ + APσ + cargo peptide<br /> | **[[2xa7]] – rAPα-2 + APβ + APμ + APσ + cargo peptide<br /> | ||
*AP-γ + AP-β + AP-μ + AP-σ | |||
**[[1w63]] – mAPγ-1 + APβ-1 + APμ-1 + APσ-1A <br /> | |||
**[[4hmy]] – mAPγ-1 + APβ-1 + APμ-1 + APσ-3 + ADP-ribosylation factor<br /> | |||
}} | |||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 11:05, 12 November 2014
<StructureSection load='2vgl' size='350' side='right' caption='Structure of Adaptin core: AP-α-2 (grey), AP-β-1 (light green), AP-μ-1 (green), AP-σ-1 (olive green) complex with inositole hexakisphosphate (PDB entry 2vgl)' scene=> Adaptin (AP) are proteins which mediate the formation of vescicles by clathrin-coated pits. The AP complex is a hetertetramer composed of 2 large AP: AP-α or AP-γ and AP-β, a medium-size AP: AP-μ and small AP: AP-σ. AP complexes connect proteins and lipids to clathrin budding sites. There are different AP complexes in mammals.
3D structures of adaptin
Updated on 12-November-2014